img

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Government Tender and Marketing are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) key manufacturers include CNADC, Boehringer-Ingelheim, MSD Animal Health, Sinopharm, Ceva, Chengdu Tianbang Biological Products Co., Ltd., Tianjin Ruipu Biological Technology Co., Ltd., Qilu Animal Health and Guangdong Wens Dahuanong Biotechnology Co., Ltd., etc. CNADC, Boehringer-Ingelheim, MSD Animal Health are top 3 players and held % sales share in total in 2022.
Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) can be divided into Live Vaccine and Inactivated Vaccine, etc. Live Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) is widely used in various fields, such as Government Tender and Marketing, etc. Government Tender provides greatest supports to the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) industry development. In 2022, global % sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) went into Government Tender filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CNADC
Boehringer-Ingelheim
MSD Animal Health
Sinopharm
Ceva
Chengdu Tianbang Biological Products Co., Ltd.
Tianjin Ruipu Biological Technology Co., Ltd.
Qilu Animal Health
Guangdong Wens Dahuanong Biotechnology Co., Ltd.
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tiankang
Zoetis
Guangdong Yongshun Biological Pharmaceutical Co Ltd
Plec Bioengineering Co., Ltd.
Segment by Type
Live Vaccine
Inactivated Vaccine

Segment by Application


Government Tender
Marketing

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) introduction, etc. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Overview
1.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Overview
1.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Segment by Type
1.2.1 Live Vaccine
1.2.2 Inactivated Vaccine
1.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Type
1.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Overview by Type (2024-2034)
1.3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Size Review by Type (2024-2024)
1.3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2024-2024)
1.4.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Type (2024-2024)
2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competition by Company
2.1 Global Top Players by Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (2024-2024)
2.2 Global Top Players by Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (2024-2024)
2.3 Global Top Players by Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (2024-2024)
2.4 Global Top Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competitive Situation and Trends
2.5.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) as of 2022)
2.7 Date of Key Manufacturers Enter into Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market
2.8 Key Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Status and Outlook by Region
3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Size by Region
3.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Region (2024-2024)
3.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Region (2024-2024)
3.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Market Size by Region
3.3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Region (2024-2034)
3.3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Region (2024-2034)
3.3.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application
4.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Segment by Application
4.1.1 Government Tender
4.1.2 Marketing
4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Application
4.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Overview by Application (2024-2034)
4.2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Size Review by Application (2024-2024)
4.2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2024-2024)
4.3.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Breakdown by Application (2024-2024)
5 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
5.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Size by Country
5.1.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Country (2024-2024)
5.1.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Country (2024-2024)
5.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Market Size by Country
5.2.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Country (2024-2034)
5.2.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Country (2024-2034)
6 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
6.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Size by Country
6.1.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Country (2024-2024)
6.1.3 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Country (2024-2024)
6.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Market Size by Country
6.2.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Country (2024-2034)
6.2.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Country (2024-2034)
7 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Region
7.1 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Size by Region
7.1.1 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Market Size by Region
7.2.1 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Region (2024-2034)
8 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
8.1 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Size by Country
8.1.1 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Country (2024-2024)
8.1.3 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Country (2024-2024)
8.2 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Market Size by Country
8.2.1 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Country (2024-2034)
8.2.2 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Country (2024-2034)
9 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Country
9.1 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Size by Country
9.1.1 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Forecasted Market Size by Country
9.2.1 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 CNADC
10.1.1 CNADC Company Information
10.1.2 CNADC Introduction and Business Overview
10.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.1.4 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.1.5 CNADC Recent Development
10.2 Boehringer-Ingelheim
10.2.1 Boehringer-Ingelheim Company Information
10.2.2 Boehringer-Ingelheim Introduction and Business Overview
10.2.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.2.5 Boehringer-Ingelheim Recent Development
10.3 MSD Animal Health
10.3.1 MSD Animal Health Company Information
10.3.2 MSD Animal Health Introduction and Business Overview
10.3.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.3.4 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.3.5 MSD Animal Health Recent Development
10.4 Sinopharm
10.4.1 Sinopharm Company Information
10.4.2 Sinopharm Introduction and Business Overview
10.4.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.4.5 Sinopharm Recent Development
10.5 Ceva
10.5.1 Ceva Company Information
10.5.2 Ceva Introduction and Business Overview
10.5.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.5.5 Ceva Recent Development
10.6 Chengdu Tianbang Biological Products Co., Ltd.
10.6.1 Chengdu Tianbang Biological Products Co., Ltd. Company Information
10.6.2 Chengdu Tianbang Biological Products Co., Ltd. Introduction and Business Overview
10.6.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.6.5 Chengdu Tianbang Biological Products Co., Ltd. Recent Development
10.7 Tianjin Ruipu Biological Technology Co., Ltd.
10.7.1 Tianjin Ruipu Biological Technology Co., Ltd. Company Information
10.7.2 Tianjin Ruipu Biological Technology Co., Ltd. Introduction and Business Overview
10.7.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.7.5 Tianjin Ruipu Biological Technology Co., Ltd. Recent Development
10.8 Qilu Animal Health
10.8.1 Qilu Animal Health Company Information
10.8.2 Qilu Animal Health Introduction and Business Overview
10.8.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.8.5 Qilu Animal Health Recent Development
10.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
10.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information
10.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Introduction and Business Overview
10.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Development
10.10 CAVAC
10.10.1 CAVAC Company Information
10.10.2 CAVAC Introduction and Business Overview
10.10.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.10.4 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.10.5 CAVAC Recent Development
10.11 Komipharm
10.11.1 Komipharm Company Information
10.11.2 Komipharm Introduction and Business Overview
10.11.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.11.5 Komipharm Recent Development
10.12 Agrovet
10.12.1 Agrovet Company Information
10.12.2 Agrovet Introduction and Business Overview
10.12.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.12.5 Agrovet Recent Development
10.13 Bioveta
10.13.1 Bioveta Company Information
10.13.2 Bioveta Introduction and Business Overview
10.13.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.13.5 Bioveta Recent Development
10.14 Jinyu Bio-Technology
10.14.1 Jinyu Bio-Technology Company Information
10.14.2 Jinyu Bio-Technology Introduction and Business Overview
10.14.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.14.5 Jinyu Bio-Technology Recent Development
10.15 Phibro Animal Health
10.15.1 Phibro Animal Health Company Information
10.15.2 Phibro Animal Health Introduction and Business Overview
10.15.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.15.5 Phibro Animal Health Recent Development
10.16 Tiankang
10.16.1 Tiankang Company Information
10.16.2 Tiankang Introduction and Business Overview
10.16.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.16.4 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.16.5 Tiankang Recent Development
10.17 Zoetis
10.17.1 Zoetis Company Information
10.17.2 Zoetis Introduction and Business Overview
10.17.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.17.4 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.17.5 Zoetis Recent Development
10.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd
10.18.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information
10.18.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Introduction and Business Overview
10.18.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.18.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.18.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Development
10.19 Plec Bioengineering Co., Ltd.
10.19.1 Plec Bioengineering Co., Ltd. Company Information
10.19.2 Plec Bioengineering Co., Ltd. Introduction and Business Overview
10.19.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2024-2024)
10.19.4 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Products Offered
10.19.5 Plec Bioengineering Co., Ltd. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industrial Chain Analysis
11.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Dynamics
11.4.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends
11.4.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Drivers
11.4.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
11.4.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors
12.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live Vaccine
Table 2. Major Company of Inactivated Vaccine
Table 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2024) & (K Units)
Table 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2024) & (US& Million)
Table 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share in Value by Type (2024-2024)
Table 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2034) & (K Units)
Table 10. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type (2024-2034)
Table 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2024) & (K Units)
Table 15. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Type (2024-2024)
Table 17. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Type (2024-2024)
Table 21. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Company (2024-2024) & (K Units)
Table 25. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Company (2024-2024)
Table 26. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Company (2024-2024)
Table 28. Global Market Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) as of 2022)
Table 32. Date of Key Manufacturers Enter into Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market
Table 33. Key Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2024-2024) & (K Units)
Table 37. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Region (2024-2024)
Table 40. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2024-2034) & (K Units)
Table 42. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Region (2024-2034)
Table 45. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2024) & (K Units)
Table 48. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application (2024-2024)
Table 51. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2034) & (K Units)
Table 53. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application (2024-2034)
Table 56. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2024) (K Units)
Table 58. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2024) (K Units)
Table 60. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2024) (K Units)
Table 64. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2024) & (K Units)
Table 68. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Country (2024-2024)
Table 71. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2034) & (K Units)
Table 72. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2024) & (K Units)
Table 76. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2034) & (K Units)
Table 80. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Country (2024-2034)
Table 107. CNADC Company Information
Table 108. CNADC Introduction and Business Overview
Table 109. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 111. CNADC Recent Development
Table 112. Boehringer-Ingelheim Company Information
Table 113. Boehringer-Ingelheim Introduction and Business Overview
Table 114. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 116. Boehringer-Ingelheim Recent Development
Table 117. MSD Animal Health Company Information
Table 118. MSD Animal Health Introduction and Business Overview
Table 119. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 121. MSD Animal Health Recent Development
Table 122. Sinopharm Company Information
Table 123. Sinopharm Introduction and Business Overview
Table 124. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 126. Sinopharm Recent Development
Table 127. Ceva Company Information
Table 128. Ceva Introduction and Business Overview
Table 129. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 131. Ceva Recent Development
Table 132. Chengdu Tianbang Biological Products Co., Ltd. Company Information
Table 133. Chengdu Tianbang Biological Products Co., Ltd. Introduction and Business Overview
Table 134. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 136. Chengdu Tianbang Biological Products Co., Ltd. Recent Development
Table 137. Tianjin Ruipu Biological Technology Co., Ltd. Company Information
Table 138. Tianjin Ruipu Biological Technology Co., Ltd. Introduction and Business Overview
Table 139. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 141. Tianjin Ruipu Biological Technology Co., Ltd. Recent Development
Table 142. Qilu Animal Health Company Information
Table 143. Qilu Animal Health Introduction and Business Overview
Table 144. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 146. Qilu Animal Health Recent Development
Table 147. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Company Information
Table 148. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Introduction and Business Overview
Table 149. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 151. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Development
Table 152. CAVAC Company Information
Table 153. CAVAC Introduction and Business Overview
Table 154. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 156. CAVAC Recent Development
Table 157. Komipharm Company Information
Table 158. Komipharm Introduction and Business Overview
Table 159. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 161. Komipharm Recent Development
Table 162. Agrovet Company Information
Table 163. Agrovet Introduction and Business Overview
Table 164. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 166. Agrovet Recent Development
Table 167. Bioveta Company Information
Table 168. Bioveta Introduction and Business Overview
Table 169. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 171. Bioveta Recent Development
Table 172. Jinyu Bio-Technology Company Information
Table 173. Jinyu Bio-Technology Introduction and Business Overview
Table 174. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 176. Jinyu Bio-Technology Recent Development
Table 177. Phibro Animal Health Company Information
Table 178. Phibro Animal Health Introduction and Business Overview
Table 179. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 180. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 181. Phibro Animal Health Recent Development
Table 182. Tiankang Company Information
Table 183. Tiankang Introduction and Business Overview
Table 184. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 185. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 186. Tiankang Recent Development
Table 187. Zoetis Company Information
Table 188. Zoetis Introduction and Business Overview
Table 189. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 190. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 191. Zoetis Recent Development
Table 192. Guangdong Yongshun Biological Pharmaceutical Co Ltd Company Information
Table 193. Guangdong Yongshun Biological Pharmaceutical Co Ltd Introduction and Business Overview
Table 194. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 195. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 196. Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Development
Table 197. Plec Bioengineering Co., Ltd. Company Information
Table 198. Plec Bioengineering Co., Ltd. Introduction and Business Overview
Table 199. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 200. Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 201. Plec Bioengineering Co., Ltd. Recent Development
Table 202. Key Raw Materials Lists
Table 203. Raw Materials Key Suppliers Lists
Table 204. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Trends
Table 205. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Drivers
Table 206. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
Table 207. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints
Table 208. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
Table 209. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Downstream Customers
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Picture
Figure 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Live Vaccine
Figure 6. Global Live Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Inactivated Vaccine
Figure 8. Global Inactivated Vaccine Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type in 2022 & 2034
Figure 11. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type in 2022
Figure 12. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type in 2022
Figure 13. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type in 2022
Figure 14. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type in 2022
Figure 17. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue in 2022
Figure 23. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Government Tender
Figure 25. Global Government Tender Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Marketing
Figure 27. Global Marketing Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Application (2024-2034) & (US$ Million)
Figure 29. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application in 2022 & 2034
Figure 30. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application in 2022
Figure 31. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application in 2022
Figure 32. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application in 2022
Figure 33. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application in 2022
Figure 36. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Cost Structure
Figure 41. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries